iPS Cell Differentiation
Clinical Applications of Epidermal Stem Cells
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 21, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Uma Keyal1, Anil Kumar Bhatta1, Xiu Li Wang1
1Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of MedicineShanghai, China.
Ultraviolet A1 (UVA1) therapy shows promise for treating skin lesions in scleroderma, offering a safer alternative to PUVA therapy with fewer side effects. This review explores optimal UVA1 dosing for scleroderma patients.
12:25Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
Published on: January 6, 2018
14:49Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: